[A novel therapeutical approach: remission of fibrosing diseases after intravenous high-dose bolus of methylprednisolone].
暂无分享，去创建一个
[1] J. Stone,et al. A clinical overview of IgG4-related systemic disease , 2011, Current opinion in rheumatology.
[2] R. Swartz. Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] T. Hendriksz,et al. Idiopathic Retroperitoneal Fibrosis Prospective Evaluation of Incidence and Clinicoradiologic Presentation , 2009 .
[4] P. Scheel,et al. Retroperitoneal Fibrosis: The Clinical, Laboratory, and Radiographic Presentation , 2009, Medicine.
[5] A. Vaglio. Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis. , 2009, Medicine.
[6] L. Defebvre,et al. Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature , 2007, Rheumatology International.
[7] M. Kupersmith,et al. Idiopathic hypertrophic pachymeningitis , 2004, Neurology.
[8] K. Hanash,et al. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. , 2002, The Journal of urology.
[9] C. Coffin,et al. Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors. , 1998, Seminars in diagnostic pathology.